HLM Venture Partners II, L.P.

HLM Venture Partners II, L.P. discloses dealings in 3 companies, chiefly Teladoc Health, Inc., Phreesia, Inc. and Tandem Diabetes Care Inc. Over a trading history stretching from 13 November 2013 to 17 December 2019, the count stands at 11 filings.

Market trades split into 1 purchase (€2.2M) and 2 sales (€56.6M). Taken together, the sales exceed the purchases by €54.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings no purchases and 2 sales.

The newest entry dates from 18 December 2019: an open-market sale of €48.0M, in Phreesia, Inc. The last purchase on record was published on 14 November 2013, which is 4,743 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.